Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

May 25, 2017

30786_dirs_2017-05-25_9c64782a-1b8f-45b2-b898-e2f9947993a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-05-23

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-23 Bio-Rad B Common Stock M 37500 $75.00 Acquired 241468 Direct
2017-05-23 Bio-Rad B Common Stock F 25605 $216.00 Disposed 215863 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-23 Non-Qualified Stock Option (right to buy) $75.00 M 37500 Disposed 2017-08-01 Bio-Rad B Common Stock (37500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12664 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The shares are held by a limited partnership of which the reporting person is a limited partner.

F4: The option vested in five equal annual installments beginning on August 1, 2008.